Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,960 articles
GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
GEHC gains FDA nod for Photonova Spectra, a next-gen photon-counting CT system to boost diagnostic precision, workflow efficiency and imaging...
GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
GEHC gains FDA nod for Photonova Spectra, a next-gen photon-counting CT system to boost diagnostic precision, workflow efficiency and imaging...
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives $53.00 Consensus PT from Brokerages
vTv Therapeutics Inc. (NASDAQ:VTVT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six...
High Tide Inc. (NASDAQ:HITI) Receives $6.13 Consensus Target Price from Analysts
High Tide Inc. (NASDAQ:HITI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five research...
📰
akoyaGO Names Mark Montoya CEO to Lead Next Era of Technology-Driven Impact
akoyaGO has named Mark Montoya Chief Executive Officer to lead its next phase of growth as foundations increasingly turn to technology to drive...
Conifer Health and Healthcare Systems of America Announce Enterprise Revenue Cycle Outsourcing Partnership
Multi-year agreement brings advanced technology, operational scale, and performance-driven revenue cycle best practices to hospitals across three...
Amazon Unleashes Zoox Robotaxis In Austin And Miami To Challenge Waymo Dominance
Amazon.com Inc’s (NASDAQ:AMZN) Zoox is preparing to expand its robotaxi service to select members of the public in Austin and Miami later this...
📰
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity
Boston Scientific's pending trial results could help to drive sales growth for years to come after lower-than-expected sales forecasts.
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- Equity-Insider.com — A protein called α-Klotho circulating in the...
Board Member At Agilent Technologies Buys $241K of Stock
It was revealed in a recent SEC filing that DOW WILSON, Board Member at Agilent Technologies (NYSE:A) made a noteworthy insider purchase on March...
Eye On Growth: Dr. Scangos Adds $359K Of Agilent Technologies Stock To Portfolio
Dr. Scangos, Director at Agilent Technologies (NYSE:A), reported an insider buy on March 23, according to a new SEC filing.
What Happened:...
GIGABYTE AORUS s'associe à VALORANT Esports EMEA
GIGABYTE AORUS soutiendra le VALORANT Champions Tour EMEA et le Game Changers EMEA pendant les saisons 2026 et 2027. Le parrainage matériel comprend...
GIGABYTE AORUS Partners with VALORANT Esports EMEA
GIGABYTE AORUS will support the VALORANT Champions Tour EMEA and Game Changers EMEA during the 2026 and 2027 seasons. The hardware sponsorship...
GIGABYTE AORUS Partners with VALORANT Esports EMEA
GIGABYTE AORUS will support the VALORANT Champions Tour EMEA and Game Changers EMEA during the 2026 and 2027 seasons. The hardware sponsorship...
Inlyte Energy Collaborates with Ervin Industries to Strengthen U.S. Battery Materials Supply Chain
The partnership combines Inlyte's iron battery technology with Ervin's century-old American manufacturer to strengthen domestic energy storage supply...
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?
JNJ stock holds strong above key SMAs for 8 months as Innovative Medicine strength, new drugs and MedTech gains fuel momentum despite patent and...
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?
JNJ stock holds strong above key SMAs for 8 months as Innovative Medicine strength, new drugs and MedTech gains fuel momentum despite patent and...
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?
JNJ stock holds strong above key SMAs for 8 months as Innovative Medicine strength, new drugs and MedTech gains fuel momentum despite patent and...
Broadcom Lands $970 Million Defense Deal To Power Air Force And Space Force Software
Broadcom Inc (NASDAQ:AVGO) is expanding its government and enterprise footprint with new contracts and product launches focused on security and...
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug
IONS wins FDA priority review for zilganersen in rare Alexander disease, with a Sept. 22, 2026, decision date backed by strong phase III data.
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug
IONS wins FDA priority review for zilganersen in rare Alexander disease, with a Sept. 22, 2026, decision date backed by strong phase III data.
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug
IONS wins FDA priority review for zilganersen in rare Alexander disease, with a Sept. 22, 2026, decision date backed by strong phase III data.
APTIM-EnergySolutions JV Awarded Seat on $999M Navy Contract for Demolition Work at Hunters Point Naval Shipyard
APTIM Radiological Services will compete for demolition, construction, supervision, and related task orders to facilitate property transfer for...
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug
IONS wins FDA priority review for zilganersen in rare Alexander disease, with a Sept. 22, 2026, decision date backed by strong phase III data.
📰
Top Analyst Reports for Eli Lilly, RTX & Abbott
Eli Lilly leads top analyst picks as GLP-1 demand, pipeline advances, and global growth momentum drive strong outlook despite rising competition...
📰
Top Analyst Reports for Eli Lilly, RTX & Abbott
Eli Lilly leads top analyst picks as GLP-1 demand, pipeline advances, and global growth momentum drive strong outlook despite rising competition...
IDEMIA Secure Transactions unterstützt Spaniens landesweite Einführung von Notfallleuchten mit seiner sicheren Konnektivität
COURBEVOIE, Frankreich, 24. März 2026 /PRNewswire/ -- IDEMIA Secure Transactions (IST), ein weltweit führender Anbieter von sicheren...
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug
Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851, advancing a promising partnered therapy.
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug
Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851, advancing a promising partnered therapy.
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug
Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851, advancing a promising partnered therapy.
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug
Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851, advancing a promising partnered therapy.
APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy
Apogee Therapeutics jumps 20% as 52-week phase II Part A data show sustained efficacy of its AD candidate, zumilokibart, with durable responses and...
APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy
Apogee Therapeutics jumps 20% as 52-week phase II Part A data show sustained efficacy of its AD candidate, zumilokibart, with durable responses and...
APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy
Apogee Therapeutics jumps 20% as 52-week phase II Part A data show sustained efficacy of its AD candidate, zumilokibart, with durable responses and...
APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy
Apogee Therapeutics jumps 20% as 52-week phase II Part A data show sustained efficacy of its AD candidate, zumilokibart, with durable responses and...
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal
Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care...
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal
Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care...
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal
Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care...
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal
Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care...
ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
ISRG records 37% margins despite tariff pressure, using cost efficiencies and recurring revenue strength to offset headwinds and sustain...
ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
ISRG records 37% margins despite tariff pressure, using cost efficiencies and recurring revenue strength to offset headwinds and sustain...
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.
ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
ISRG records 37% margins despite tariff pressure, using cost efficiencies and recurring revenue strength to offset headwinds and sustain...